Pharmaceuticals major Ranbaxy Laboratories today said it had launched the generic versions of Atorvastatin tablets, 10mg, 20 mg, 40mg and 80mg in Italy and Sweden and 10mg, 20mg and 40mg in the Netherlands, after receiving approval from the respective local regulatory authorities.
58512
Ranbaxy launches generic versions of Atorvastatin in Italy, Sweden and the Netherlands
83853
Novel inhaled formulation of dihydroergotamine effective for a broad spectrum of migraine:
163585
Athex weighs results
124569
BioAlliance Pharma announces the
154789
Long before valtrex starts working
153548
Market for RFID applications in pharmaceuticals estimated to
126233
Astex achieves milestones in drug discovery collaboration
134016
European medicines Agency recommends suspension of Avandia, Avandamet and Avaglim
47238
MedNest incorporates and launches PharmaNest
70808
Merck presents positive data
20188
Ranbaxy gains 4.8%;
113036
Ranbaxy has support at Rs 236:
165699
Pharmaceutical markets in India
72621
OncoGenex Pharmaceuticals files shelf registration statement
51435
Generic medicines could offer substantial saving
37199
Bionovo (bnvi) to present positive results from phase 2 trial of Menerba
5285
Azovstal increased production in Q1 2010